Vinyl chloride (VC) is both a known carcinogen and a regulated chemical, and its production capacity has almost doubled over the ltst 20 years, currently 27 million tons/year woddwide.
hbtm://ehanete1.n iebs..nib.gopv/2OOO/108p579-588kieIhorn/abstract/ btml Vinyl chloride (VC) is one of the best-studied chemicals. Because of evidence that VC was carcinogenic in both animal studies and in human case reports in the early 1970s, there were drastic changes in the production methods and in occupational hygiene in the VC/polyvinyl chloride (PVC) industry in the Western World, with the closure ofsome factories that were not able to conform to the strict regulations and occupational exposure limits. VC levels in PVC resins and products were also restricted. As a result of the strict occupational exposure limits, no cases of angiosarcoma of the liver (ASL), the rare tumor associated with VC Historical Background VC was first used commercially in the 1920s, but it was not until the 1930s that techniques were devised to polymerize VC into stable forms of PVC. Polymerization is a batch process and takes place in a reactor (autoclave) under controlled conditions. Once the polymerization has ended, VC is emptied into degassing tanks. The reactor has to be cleaned periodically because a film of PVC forms on the inside wall of the reactor. Although this is now performed with solvents or automatic high-pressure jets, previously this task was a manual process requiring workers to use spatulas or hammers and chisels; the workers were exposed to high concentrations of VC up to 1,000 ppm (2, 600 mg/m3) and possibly even higher peaks of exposure. As a result, some of these workers suffered from a specific pathologic syndrome called "vinyl chloride disease," with symptoms including earache and headache, dizziness, unclear vision, fatigue and lack of appetite, nausea, sleeplessness, breathlessness, stomachache, pain in the liver/spleen area, pain and tingling sensation in the arms/legs, cold sensation at the extremities, loss of libido, and weight loss (2) . Clinical findings included scleroderma-like changes in the fingers, with subsequent bony changes in the tips of the fingers described as acro-osteolysis; peripheral circulatory changes similar to Raynaud's phenomenon; and enlargement of the liver and spleen, with a specific histologic appearance and respiratory manifestations (3) (4) (5) (6) .
After the case series on hepatic angiosarcoma among workers exposed to vinyl chloride (2) was published in 1974, several further case series and small epidemiologic studies, primarily with emphasis on hepatic tumors, were published in the 1970s and 1980s . These reports showed that exposure to high levels of VC were associated with the incidence of ASL. Other (non-ASL) cancer sites and types that may be connected with VC exposure include tumors of the liver (e.g., non-angiosarcoma), particularly hepatocellular carcinoma; respiratory system; digestive system other than the liver; lymphopoietic and hematopoietic tissue; brain and other central nervous system; and malignant melanoma.
Parallel to human case reports, after the first reports of the carcinogenicity of VC in rats (29, 30) , extensive studies were carried out in the rat, mouse, and hamster on the effects of oral (31) (32) (33) 
VC Environmental Contamination and Remediation
Reports from several countries (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) recently showed high levels of VC contamination in soil, groundwater, aquifers, and wells near landfill and industrial waste disposal sites that were not located near VC/PVC production facilities. VC concentrations were up to 12 mg/L in some groundwater samples and up to 230 mg/m3 in landfill gas samples (Table 2) . VC can be formed microbially, under anaerobic conditions, from the reductive dehalogenation of the more highly chlorinated chloroethenes: perchloroethylene (PCE), trichloroethene (TCE) , and the dichloroethene isomers, cis-1 ,2-dichloroethene (cis-1 ,2-DCE), trans-1,2-DCE, and 1,1-DCE (Figure 1 ) (59) (60) (61) (62) . PCE and TCE are used as industrial solvents for degreasing and cleaning metal parts and electronic components and in dry cleaning. Careless handling, storage, and disposal, as well as the high chemical stability of these compounds, have made them, and consequently VC, some of the most frequently encountered groundwater contaminants. Although VC may be further degraded to less and nonchlorinated ethenes and possibly finally to carbon dioxide and ethane, this proceeds at a slow rate under highly reducing conditions (63) (64) (65) ; as a consequence, there can be a build-up of VC in landfills and surrounding areas.
Several field studies of PCE/TCE-contaminated landfill sites and aquifers (61, (66) (67) (68) (69) (70) After an accident in Schonebeck, Germany, in June 1996, which involved the derailment of a train carrying VC and the subsequent fire, 325 persons were documented as having acute symptoms, but these correlated with exposure to the pyrolytic products (e.g., hydrochloric acid) and not to VC itself. Over 1,000 tons of VC were involved, of which approximately 250 tons burned and 350 tons were reclaimed after the fire. One hundred fifty tons of HCI were released (79) . According to measurements first taken 14 hr after the fire, the maximum concentrations of VC were approximately 80 mg/m3 near the train and 25 mg/m3 at 200 m from the center of the fire (80) . In a study of 29 individuals exposed as a result of this accident, there was a significant increase in chromosomal abberrations as compared to an unexposed control group (81) .
With the improvement in industrial hygiene and stricter emission controls in many countries, the general population is not usually exposed to emissions from VC and PVC production facilities, but there are exceptions. For example, Zhao et al. (82) reported that, in China, workers and their families were exposed to VC because the dormitories were near or even on the campus of the PVC/VC plant. In 1988, maximum and mean daily concentrations of 12.7 and Reviews * Vinyl chloride 4.4 mg/m3, respectively were measured in dormitories 50 m away from the plant (82).
Occupational Exposure Levels
Industrial environments associated with VC exposure include VC production plants, VC polymerization (PVC production) plants, and PVC processing factories. For example, the number of workers exposed to VC has been estimated to be approximately 80 (Table 3) . Some VC workers, autoclave cleaners in particular, were estimated to be exposed to as much as 1,000 ppm (2,600 mg/m3) in the 1950s and earlier (85) (86) (87) (88) (89) .
The exposure was reduced to one-tenth of this by the mid-1970s. After 1975, levels were usually < 1-5 ppm (< 2.6-13 mg/m3) in many countries.
In many countries, factories that could not reduce the emissions of VC to satisfy the rigorous laws in the early 1970s were forced to close. In other countries, this was not possible for socioeconomic reasons; thus, large factories with old-fashioned technologies continued the manufacturing process (90) and workers continued to be exposed to high levels of VC (Table 4) .
Recent data from Croatia may reflect the actual conditions still prevalent in some countries. A retrospective investigation of the exposure to VC has been performed in 37 autoclave workers in Split, Croatia, who were maximally exposed to the emission of VC by the nature of their job (emptying and cleaning) in a suspension polymerization plant. The investigation covered the period from 1969 to 1987, after which the factory was closed due to the high emission of VC. Data show that the 37 workers were exposed over this period to average VC concentrations of approximately 500 ppm (1,300 mg/mi3) (90, 92) . As a consequence of this high exposure to VC, a disproportionately large number of ASL mortalities have been reported in Croatia (Table 5) . Angiosarcoma of the Liver ASL, also known as hemangioendothelial sarcoma, is an extremely rare liver tumor and is difficult to diagnose. ASL constitutes only 2% of all primary tumors of the liver in the general population; for example, from 1975-1987 figures in England and Wales, there was an annual incidence of 1.4 cases/10 million people (101) . ASL has been associated only with exposure to VC, Thorotrast (a Table 2 Vinyl chloride found in landfilVwaste disposal sites as a gas, in leachate, and in groundwater formed probably from degradaton of higher chloroethenes. Two larger studies combined earlier studies from the United States (112) and Europe (113) and updated the mortality follow-up. These studies have been or are currently being updated again (114, 115) .
Wong et al. (112) updated earlier U.S.
studies (8, 9) and subsumed others (10) (11) (12) (13) (14) (15) (26, 27) and the former Soviet Union (28).
IPCS Task Group Findings
The IPCS Task Group (1) reported that "there is a 5-fold excess risk for liver cancer observed among workers exposed to V"; this occurs primarily in PVC polymerization factories, where the highest exposures to VC occur ( Table 6 ). Much of the excess risk can be attributed to the excess risk for ASL. In the European study, Simonato et al. (113) found a 45-fold excess risk for ASL in workers exposed to VC > 10,000 ppm-years as compared to workers exposed to < 2,000 ppm-years (Table 7 ). In the European study, there was histopathologic confirmation of type of liver cancer for 17 out of 24 liver cancers; of those confirmed, 16 were ASL. In the U.S. study, Wong et al. (112) registered 21 out of 37 liver cancer deaths as ASL. In the Canadian study, Theriault and Allard (23) reported that all 8 of the liver cancer deaths were ASL; this was also the case for the 3 liver cancer deaths reported in the French study by Laplanche et al. (27) . There is no information about whether liver cancers were ASL in the German study by Weber et al. (24) , and in the Russian study, Smulevich (28) reported no diagnosed liver cancers. Some ASL cases in VC-exposed workers have probably remained undiagnosed; the causes of these deaths may have been recorded on death certificates as unspecified liver cancers or other liver-associated disease.
The risk for hepatocellular carcinoma (HCC) was examined in several studies. Simonato et al. (113) Reviews * Kielhorn et al.
study in which the dose-response relationship was examined, Simonato et al. (113) observed no association of brain tumors with cumulative exposure to VC. The overall epidemiologic evidence suggests a possible risk for brain tumors among VC workers. An increase in lung cancer among VC workers had been reported in some early studies (10) . However, there was no excess risk indicated in the two largest studies-the European (113) and U.S. (112) studies-or in the other four smaller studies (23, 24, 27, 28) . No associations were found for either the duration of exposure/employment in the U.S. (112) or European (113) studies, or for cumulative exposure to VC in the European study (113) .
An excess risk for malignant lymphomas was reported in some early studies (10, 14, 25, 28) , but no excess risk was observed in the two largest cohorts [the U.S. (112) and European studies (113) ] or in the Canadian cohort (23) . In both the Russian (28) and German (24) studies, an excess risk for leukemia and lymphoma combined was observed.It should be noted that different methods of disease classification were used and sometimes lymphomas were grouped with malignant myelomas. The overall results of these studies do not show any significant increased risk for lymphomas or leukemia.
Since the IPCS Task Group meeting in January 1999 in Hanover, Germany, the update of the study by Wong et al. ( 112) has been completed (114) . Specific cancers that showed meaningful excesses both through 1982 and through 1995 included cancers of the liver and the biliary tract (mostly due to a large excess of deaths due to ASL), the brain, and the connective and soft tissues. Of several causes of death previously believed to be related to VC exposure, no excesses were observed; these include lung cancer, cancers of lymphatic and hematopoietic tissue, emphysema and pneumoconioses, and other lung diseases, including chronic obstructive pulmonary disease.
VC Initiation of Hepatocarcinogenesis
Carcinogenesis is a multistep process. In the last few years, progress has been made in the understanding of a possible mechanism of initiation of hepatocarcinogenesis by VC. Recent studies (1, (118) (119) (120) (121) indicate that VC acts as a genotoxic carcinogen. After metabolic activation of VC into chloroethylene oxide (CEO) by cytochrome P450 isozyme 2E1 (CYP2E1), it exerts various genotoxic effects (including gene mutations and chromosomal aberrations) in different organisms, including bacteria, yeasts, mammalian cells in culture, Drosophila, rodents, and humans [reviewed by Giri (122) and updated by the IPCS (1)].
Among the mutagenic events induced by VC, base pair substitutions appear to be the most frequent (118) .
In vitro studies have demonstrated that CEO and chloroacetaldehyde can alkylate nucleic acid bases (Figure 2) (1,118,119,123 ). 7-(2'-Oxoethyl)guanine, the major DNA adduct formed by VC and CEO, does not exhibit promutagenic properties. In contrast, four minor adducts, 1,M-ethenoadenine (-A), 3,N4-ethenocytosine (-C), N2,3-ethenoguanine (N2,3-sG), and 1,N2-ethenoguanine (1 ,N2-EG), show promutagenic properties, inducing mainly base pair substitutions and a low level of frameshift mutations (124) . Sitespecific mutagenesis studies in Escherichia coli and in mammalian cell lines have shown that both EG and £C can induce G:C -A:T transitions; EC can also lead to C:G -A:T transversions (125, 126) . EA can induce misincorporation of G, C, or A during replication, thus inducing the base-pair substititions A:T -* C:G, A:T -* G:C, or A:T -e T:A (127,128).
7-(2'-Oxoethyl)guanine and three etheno adducts (-A; £C; and N2,3-EG; Figure 2 ) have been detected in DNA from rats and mice exposed to VC (123, (128) (129) (130) (131) . Highly variable background levels ofcA and -C were found in all the tissues examined (132, 133) . After exposure of rats to VC, significantly elevated levels of sA and EC were measured in most tissues, except the brain; there were also no significant increases of EA levels in the kidney and spleen (121, 134) .
The liver is one of the primary targets for VC-induced carcinogenesis in rats and humans. Mutations have been found in liver tumors associated with VC exposure. Mutations, all A:T -* T:A transversions, have been described in the p53 gene in three human ASL cases (Table 8) . In human ASL, the Ki-ras gene is also activated through a G:C --A:T mutation at base 2 of codon 13 ( Table  9) . Ki-ras gene activation has not been found in rat ASL (141, 142) . However, 44% of rat ASL cases were found to contain a mutated p53 gene: most mutations were base pair substitutions that involved mainly A:T base pairs (137) . The data suggest the existence of hot spots for mutations in the p53 gene; one mutation found in two rat ASL cases was equivalent to the same mutation characterized in one human ASL case associated with VC exposure. In rat HCC induced by VC, the Ha-ras gene is activated through an A:T e T:A transversion in codon 61 ( Table 9) .
The mutation spectra observed in liver tumors (ASL and/or HCC) that are associated with VC exposure in humans and rats are clearly distinct from those observed in sporadic liver tumors or in hepatic tumors associated with other exposures. In rats, the substitution mutations found at A:T base pairs in the ras and p53 genes are consistent with the promutagenic properties of CA and with the accumulation and persistence of this lesion in hepatic DNA (121) . Altogether, available data suggest that etheno adducts 
Risk Assessment Based on Human Epidemiologic Data
Simonato et al. (113) performed a regression analysis from epidemiologic data to assess the relative risk of liver cancer and ASL in occupational exposure to VC using the variables cumulative exposure (ppm-years) and years since first employment. On the basis of this regression analysis, Simonato et al. (113) calculated the absolute risk of ASL per 100,000 (Table 7) . For example, for workers exposed for > 25 years to < 80 ppm (i.e., < 2,000 ppm-years), there is a risk of 6.2 as compared to those who are exposed for only a few years at the same exposure level. At higher exposure levels (2,000-5,999 ppmyears), the risk increases to 42.2.
Physiologically Based Pharmacokinetic Model
In order to perform quantitative risk assessment using animal bioassays, physiologically based pharmacokinetic models (PBPKs) have been developed to derive the concentration of active metabolite at the critical target site, the liver, and to extrapolate this from animals to humans. The PBPK model should be validated by taking into account the known metabolic pathways and by using experimentally determined metabolic constants.
Clewell et al. (143) developed a model in which the initial metabolism of VC was hypothesized to occur via two saturable pathways (one representing high-affinity, low-capacity oxidation by CYP2E1 and one representing low-affinity, high-capacity oxidation by other P450 isozymes), producing CEO as an intermediate product in both cases. Chloroacetaldehyde (from CEO) was modeled as the major substrate of glutathione conjugation, with a lesser amount of CEO as the substrate of glutathione S-epoxide transferase. The model was similar to that proposed by Chen and Blancato (144) with regard to number and type of compartments, physiologic parameters, and the assumption that metabolism of VC takes place only in the liver; the authors used partition coefficients from the literature (145) . The metabolic parameters for the two oxidative pathways were estimated from gas uptake experiments (146) ; in this model, it was assumed that the reactive VC metabolites further degrade to carbon dioxide, react with glutathione, or react with cellular macromolecules. Parameters for subsequent metabolism were taken from the PBPK model for vinylidene chloride (147) .
This PBPK model (143) was used to predict the total production of reactive metabolites from VC in the animal bioassays and in human exposure scenarios. These measures of internal exposure were then used in the linearized multistage model (LMS) (148) to predict the risk associated (113) . For example, in the suibgroup that Simonato et at. (113) estimated to have the lowest exposures (0-2,000 ppm-years), the reported incidence of ASL was 6.2/100,000 (Table 7) . In contrast, Reitz et al. (150) calculated a maximum likelihood estimate of 188-736 cases/100,000 for exposures of 500-2,000 ppm-years. Thus, this risk assessment (150) using a PBPK model predicted almost two magnitudes more liver cancer cases than were actually reported.
Oral Exposure Studies
The present HEAST (149) , which uses results from the rat bioassay of Feron et al. (31) , gives a slope factor of 1.9 per mg/kg/day and an oral unit risk of 5.4 pg/L x 10-5. These values are based on the U.S. EPA evaluations of 1984 and 1985 for which a PBPK model was not used. These values are under review and are subject to change.
By using results from the rat bioassay of Til et al. (32) and by applying the linearized multistage model, the human lifetime exposure for a 10-5 excess risk of ASL was calculated to be 20 pg/day (151) . In this report, it was assumed that, in humans, the number of cancers at other sites may equal that of ASL, so that a correction (factor of 2) for cancers other than ASL is justified. VC Environmental Health Perspectives * VOLUME 108 
Conclusion
VC is a chemical of interest in many fields of study. Workers in some parts of the world were and may still be exposed to high levels of VC, although it is a known carcinogen and is regulated in many countries. Fortunately, it seems that ASL is correlated with only high exposures over long periods. Because ASL has a latency of approximately 20 years, mortality from ASL caused by VC exposure is still to be expected in the next few years. With further improvements in industrial hygiene in countries all over the world, perhaps VC-induced ASL mortalities will become a phenomenon of the past.
The detection of VC as a degradation product of some chlorinated solvents is an indication of the intricate problems that may be attributed to past and future chemical waste deposits. Progress in remediation processes should be able, at least in part, to resolve these problems.
Research into the mechanisms of carcinogenesis has been initiated because ASL is a rare tumor and its occurrence in VC workers can be correlated with estimated VC exposure. Studies into mutation spectra observed in rat and human liver tumors (ASL and/or HCC) have shown that etheno adducts, in particular 1,1V-ethenoadenine (-A), have promutagenic properties and are responsible for substitution mutations found at A:T base pairs in the ras and p53 genes.
Since the 1970s it has been possible to monitor exposed VC workers and to keep records of mortality cases; a large amount of data is now available for epidemiologic studies, which are being continually updated. Using animal studies and various models, researchers have attempted to predict the risk of mortality and to extrapolate predictions from animals to humans. By comparing these predictions with human ASL mortality records, current risk assessment methodology can be validated.
